SEC Form 4 · accession 0000904454-17-000551

Clovis Oncology, Inc. · CLVS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Aug 4, 2017

Accepted (ET)

Aug 8, 2017 · 4:03 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001466301

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Aug 4, 2017	S	18,450	$78.61	D	17,056	I	By DP VII Associates, L.P.
Common Stock^F2	holding	—	—		—	1,000,000	I	By Domain Partners VII, L.P.
Common Stock^F2	holding	—	—		—	92,518	I	By One Palmer Square Associates VII, LLC
Common Stock^F2	holding	—	—		—	32,760	I	By Domain Associates, LLC
Common Stock	holding	—	—		—	2,185	D
Common Stock^F3	holding	—	—		—	2,927	I	By Susan W. and James C. Blair Family L.P.

No Table II lines on this filing.

F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.19 to $79.19. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2The Reporting Person is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of Domain Partners VII, L.P. and DP VII Associates, L.P., and of Domain Associates, LLC. Pursuant to Instruction 4(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities owned by each such entity, however he disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him.
F3The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.